Pathkey.AI Ltd engages in the development of digital tools that enhance healthcare experience for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process for biopharma, MedTech, government, and healthcare organizations. The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025. Pathkey.AI Ltd was incorporated in 1994 and is based in Milsons Point, Australia.
Metrics to compare | OPL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOPLPeersSector | |
---|---|---|---|---|
P/E Ratio | −2.5x | −4.8x | 11.7x | |
PEG Ratio | −0.06 | −0.03 | 0.01 | |
Price/Book | −20.2x | 2.4x | 2.4x | |
Price / LTM Sales | 32.0x | 2.0x | 2.2x | |
Upside (Analyst Target) | - | 43.1% | 17.5% | |
Fair Value Upside | Unlock | 10.0% | 3.5% | Unlock |